160 related articles for article (PubMed ID: 11324457)
1. Prevention of intima hyperplasia by mitogen-activated protein kinase antisense oligodeoxynucleotide.
Huang SL; Ding B; Shan B; Yu QS; Guo ZG
Acta Pharmacol Sin; 2000 Apr; 21(4):313-7. PubMed ID: 11324457
[TBL] [Abstract][Full Text] [Related]
2. Target selectivity of MAPK phosphorothioate antisense ODN on p42/p44, p38 MAPK, and JNK protein expression and its inhibitory effect on VSMC DNA synthesis.
Huang SL; Ding B; Li J; Yi FX; Liu WL; Yu QS; Guo ZG
Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):613-7. PubMed ID: 10678124
[TBL] [Abstract][Full Text] [Related]
3. Effect of antisense mitogen-activated protein kinase oligonucleotides on rat vascular smooth muscle cell proliferation induced by EGF in vitro.
Huang SL; Ding B; Yu QS; Guo ZG
Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):489-93. PubMed ID: 10375818
[TBL] [Abstract][Full Text] [Related]
4. Antisense Ca(2+)-calmodulin dependent protein kinase oligonucleotide inhibits bFGF-induced proliferation of rat vascular smooth muscle cells.
Huang SL; Ding B; Li J; Yu QS; Guo ZG
Acta Pharmacol Sin; 2000 Mar; 21(3):229-33. PubMed ID: 11324421
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
Zhang SQ; Ding B; Guo ZG; Li YX
Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of MAP kinase antisense oligonucleotide on angiotensin II-induced c-myc gene expression and proliferation of rat cardiac fibroblast.
Ding B; Huang SL; Zhang SQ; Li YX
Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):934-40. PubMed ID: 11270995
[TBL] [Abstract][Full Text] [Related]
7. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F
J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
[TBL] [Abstract][Full Text] [Related]
9. [The inhibitory effect of antisense phosphorothioate c-myc oligodeoxynucleotide on intimal hyperplasia in rat abdominal aortae after injury with a balloon catheter].
Wang J; Hu D; Liu K
Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):388-91. PubMed ID: 10923448
[TBL] [Abstract][Full Text] [Related]
10. VEGF protects bovine aortic endothelial cells from TNF-alpha- and H2O2-induced apoptosis via co-modulatory effects on p38-and p42/p44-CCDPK signaling.
Liu WL; Guo X; Chen QQ; Guo ZG
Acta Pharmacol Sin; 2002 Jan; 23(1):45-9. PubMed ID: 11860736
[TBL] [Abstract][Full Text] [Related]
11. [Focal adhesion kinase and mitogen activated protein kinase are involved in vascular smooth muscle cells migration and proliferation stimulated by fibronectin].
Yin H; Wang L; Huo Y; Peng X; Xia C; Tang C
Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):622-5. PubMed ID: 12133485
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effects of antisense oligonucleotides targeting mitogen-activated protein kinase (MAPK) mRNA on neonatal rat cardiac fibroblast proliferation induced by Ang II and EGF].
Ding B; Huang SL; Li YX
Sheng Li Xue Bao; 1999 Aug; 51(4):397-406. PubMed ID: 11498967
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
[TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor stimulated vascular smooth muscle cell proliferation and its molecular mechanism.
Li J; Huang SL; Guo ZG
Acta Pharmacol Sin; 2000 Apr; 21(4):340-4. PubMed ID: 11324463
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligodeoxynucleotides downregulated c-sis mRNA expression to inhibit proliferation of vascular smooth muscle cells.
Tang QD; Lin SG; Yu XY
Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):36-42. PubMed ID: 10437122
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
17. Effects of p38 and p42/p44 CCDPK signaling on H2O2-induced apoptosis in bovine aortic endothelial cells.
Liu WL; Guo X; Guo ZG
Acta Pharmacol Sin; 2000 Nov; 21(11):991-6. PubMed ID: 11501067
[TBL] [Abstract][Full Text] [Related]
18. Treatment of vascular smooth muscle cells with antisense phosphorothioate oligodeoxynucleotides directed against p42 and p44 mitogen-activated protein kinases abolishes DNA synthesis in response to platelet-derived growth factor.
Robinson CJ; Scott PH; Allan AB; Jess T; Gould GW; Plevin R
Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):123-7. PubMed ID: 8947476
[TBL] [Abstract][Full Text] [Related]
19. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
[TBL] [Abstract][Full Text] [Related]
20. Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia.
Ahn JD; Morishita R; Kaneda Y; Kim HS; Chang YC; Lee KU; Park JY; Lee HW; Kim YH; Lee IK
Gene Ther; 2002 Dec; 9(24):1682-92. PubMed ID: 12457282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
